Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Schedule of Accounts and Grants Receivable

Accounts and grants receivable by source, as of (in thousands):

	March 31, 2024		December 31, 2023
National Institutes of Health – Grant	$	96	$	96
Accounts receivable from customers		82		15
Total	$	178	$	111

Schedule of Revenue

Revenue by source (in thousands):

	Three months ended March 31,
	2024		2023
NIH - grant	$	-	$	41
Clinical trial revenue		515		238
Contract manufacturing		33		-
Total	$	548	$	279